| 영문 | immunotherapy | 한글 | 면역요법 |
|---|---|---|---|
| 설명 | 감염증일 경우에 병원체나 그것이 내는 독소에 대한 면역체를 체내에 주입하거나, 인공적으로 면역체를 생산 또는 증강시켜 치료에 도움이 되게 하는 요법. 면역체를 체내에 주입하는 것은 면역혈청요법으로 대표되는 수동적 면역요법이며, 이것에는 콜레라-유행성 뇌막염-성홍열 등과 같이 항균혈청에 의한 방법과 디프테리아-파상풍-가스괴저 등과 같이 항독소 혈청에 의한 것이 있다. 인공적으로 면역체를 생산-증가시키는 것은 능동적 면역요법으로, 광견병-백일해-장티푸스-파라티푸스 등의 경우와 같이 백신주사로 면역체를 능동적으로 생산-증강시키는 방법이다. |
||
| ABL | abetalipoproteinemia; acceptable blood loss; African Burkitt lymphoma; Albright-Butler-Lightwood [sy... |
|---|---|
| BW | bacteriological warfare; bed wetting; below waist; biological warfare; biological weapon; birth weig... |
| ITx | Immunotherapy |
| CAI | cellular adaptive immunotherapy; complete androgen insensitivity; computer-assisted instruction |
| IT | immunological test; immunotherapy; implantation test; individual therapy; information technology; in... |
| A.S.I. | Active Specific Immunotherapy |
|---|---|
| AIT | Adoptive immunotherapy |
| IT | Immunotherapy |
| LNIT | Local nasal immunotherapy |
| RIT | Rush immunotherapy |
| biological immunotherapy | <immunology> Treatment of disease by stimulating the bodys own immune system. This is a type of therapy currently being researched as a treatment for cancer. (16 Dec 1997) |
|---|
| passive immunotherapy | <immunology> A process in which individuals with advanced disease (who have low levels of HIV antibody production) are infused with plasma rich in HIV antibodies or an immunoglobulin concentrate (HIV Ig) from such plasma. The plasma is obtained from asymptomatic HIV-positive individuals with high levels of HIV antibodies. (09 Oct 1997) |
|---|---|
| immunotherapy | <immunology> Treatment of disease by stimulating the bodys own immune system. This is a type of therapy currently being researched as a treatment for cancer. (16 Dec 1997) |
| immunotherapy, active | Active immunization where vaccine is administered for therapeutic or preventive purposes. This can include administration of immunopotentiating agents such as bcg vaccine and corynebacterium parvum as well as biological response modifiers such as interferons, interleukins, and colony-stimulating factors in order to directly stimulate the immune system. (12 Dec 1998) |
| immunotherapy, adoptive | Form of adoptive transfer where cells with antitumour activity are transferred to the tumour-bearing host in order to mediate tumour regression. The lymphoid cells commonly used are lymphokine-activated killer (lak) cells and tumour-infiltrating lymphocytes (til). This is usually considered a form of passive immunotherapy. (12 Dec 1998) |
| immunotherapy, allergy | Stimulation of the immune system with gradually increasing doses of the substances to which a person is allergic, the aim being to modify or stop the allergy war (by reducing the strength of the IgE and its effect on the mast cells). This form of treatment is very effective for allergies to pollen, mites, cats, and especially stinging insects (e.g., bees, hornets, yellow jackets, wasps, velvet ants, fire ants). Allergy immunotherapy usually takes 6 months to a year to become effective and shots (injections) are usually required for 3-5 years. (12 Dec 1998) |
| biological | Pertaining to biology. (18 Nov 1997) |
| biological agent | <microbiology> A disease-causing microorganism or virus, or other toxic biological matter, which is used as a weapon during war. (21 Mar 1998) |
| biological assay | <technique> Once a pharmaceutical protein is isolated from the cells in which it was grown, researchers perform tests to measure the protein's biological activity. It must maintain a certain minimal level of biological activity to be used for animal or clinical testing or, later, for market. Researchers also test to confirm that the isolated protein is identical to the desired protein. (21 Mar 1998) |
| biological assessment | A specific process required as part of an environmental assessment. An evaluation of potential effects of a proposed project on proposed, endangered, threatened, and sensitive animal and plant species and their habitats. (05 Dec 1998) |
| biological availability | The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. (12 Dec 1998) |
| biological chemistry | The scientific study of the chemistry of living cells, tissues, organs and organisms. (09 Oct 1997) |
| biological clock | <biology, physiology> An internal biological mechanism which controls certain biological rhythms and biocycles, such as metabolism, sleep cycles, photosynthesis. (21 Mar 1998) |
| biological clocks | The physiological mechanisms that govern the rhythmic occurrence of certain biochemical, physiological, and behavioural phenomena in plants and animals. The pineal gland, which receives input from the optic nerves and connects to the hypothalamus, may be the biological clock in humans. (12 Dec 1998) |
| biological coefficient | Rarely used term denoting the energy expended by the body at rest. (05 Mar 2000) |
| biological containment | <molecular biology> Refers to any number of methods to contain genetically engineered organisms by creating biochemical barriers to prevent them from growing outside the laboratory. In the case of bacteria and yeasts, genes in the organisms may be altered so that they need to have a supply of a nutrient that is normally found only in the laboratory. (21 Mar 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|